Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 1006-1014

  McGowan, Tracy ^a   Vaccaro, Nicole M ^b   Beaver, Jessica S ^c   Massarella, Joseph ^b   Wolfson, Marsha ^a  

^a Ortho Biotech Products LP   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c Targacept   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG ADMINISTRATION; ERYTHROCYTE COUNT; FEMALE; HUMAN; KIDNEY DISEASE; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; ANEMIA; CHRONIC DISEASE; DIALYSIS; DRUG ADMINISTRATION SCHEDULE; EPOETIN ALFA; ERYTHROCYTE COUNT; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, SUBCUTANEOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETICULOCYTE COUNT; TREATMENT OUTCOME; UNITED STATES;

EID: 49149120764     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05671207     Document Type: Article

References (14)

1. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162: 1401-1408, 2002
2. PROCRIT (Epoetin alfa) Prescribing Information, Raritan, NJ, Ortho Biotech Products, L.P., 2008
3. Frenken LA, Verberckmoes R, Michielsen P, Koene RA: Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. Nephrol Dial Transplant 4: 782-786, 1989
4. Lim VS, Kirchner PT, Fangman J, Richmond J, DeGowin RL: The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. Am J Kidney Dis 14: 496-506, 1989
5. Piccoli A, Malagoli A, Komninos G, Pastori G: Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia. J Nephrol 15: 565-574, 2002
6. Provenzano R, Garcia-Mayol L, Suchinda P, Von Harfitzsch B, Woollen SB, Zabaneh R, Fink JC: Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 61: 392-405, 2004
7. Provenzano R, Bhaduri S, Singh AK: Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 64: 113-123, 2005
8. Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M: Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review. Nephrol Dial Transplant 20: 2146-2152, 2005
9. Benz R, Schmidt R, Kelly K, Wolfson M: Epoetin alfa once every 2 weeks is effective for initiation of treatment of anemia of chronic kidney disease. Clin J Am Soc Nephrol 2: 215-221, 2007
10. Spinowitz B, Germain M, Benz R, Wolfson M, McGowan T, Tang KL, Kamin M, for the Epoetin Alfa Extended Dosing Study Group: A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease. Clin J Am Soc Nephrol 3: 1015-1021, 2008
11. Markham A, Bryson HM: Epoetin alfa: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 49: 232-254, 1995
12. Cheung WK, Goon BL, Guilfoyle MC, Wacholtz MC: Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects. Clin Pharmacol Ther 64: 412-423, 1998
13. Olsson-Gisleskog P, Jacqmin P, Perez-Ruixo JJ: Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects. Clin Pharmacokinet 46: 159-173, 2007
14. Brockmoller J, Kochling J, Weber W, Looby M, Roots I, Neumayer HH: The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients. Br J Clin Pharmacol 34: 499-508, 1992